Showing 17,321 - 17,340 results of 30,748 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 100 ((mean decrease) OR (nn decrease)) ))', query time: 0.97s Refine Results
  1. 17321

    Acceleration of nephron maturation and reduction of cap mesenchyme at E18.5 in Bmp7 knockout kidneys. by Mayumi Tomita (450540)

    Published 2013
    “…Scale bars: 100 µm (<b>D, G, L</b>) or 50 µm (<b>E, F, H, J</b>).…”
  2. 17322
  3. 17323
  4. 17324
  5. 17325

    <i>In vitro</i> and <i>in vivo</i> antitumor activity of PEITC and Trisenox in imatinib resistant cells. by Jérome Kluza (5649763)

    Published 2011
    “…Cumulative survival data were compiled from two separate experiments and presented by a Kaplan–Meier survival analysis. GFP+ DA1-3b/M2 bearing mice were treated with Trisenox (4 mg/kg ip 5days/week) or PEITC (50 mg/kg ip 5days/week). …”
  6. 17326

    Light-induced upregulation associates with H2Bub enrichment over transcribed regions. by Clara Bourbousse (150199)

    Published 2012
    “…(C) Time-series distribution of H2Bub levels over genes that are upregulated by light and marked at 6 h (n = 189). Mean H2Bub levels from all tiles for genes in each category were plotted on a schematized gene scaled to accommodate different transcribed region lengths (represented from 0 to 100%). …”
  7. 17327
  8. 17328

    Image 1_Within- and between-day test–retest reliability of responses to rapid bilateral anterolateral magnetic phrenic nerve stimulation in healthy humans (ReStim).jpg by Kyle G. P. J. M. Boyle (15243982)

    Published 2025
    “…Between days, P<sub>di,mean</sub> reliability was also “good” (ICC range 0.79–0.87) at stimulator outputs of 20%–50% of maximum, but “moderate” (ICC range 0.56–0.72) at stimulator outputs of 60%–100%. …”
  9. 17329

    Supplementary Material for: Clinical Utility of KidneyIntelX in Early Stages of Diabetic Kidney Disease in the CANVAS Trial by Lam D. (11931392)

    Published 2022
    “…<b><i>Introduction:</i></b> KidneyIntelX is a composite risk score, incorporating biomarkers and clinical variables for predicting progression of diabetic kidney disease (DKD). …”
  10. 17330
  11. 17331

    Increased SIRT1 expression and deacetylase activity by cilostazol. by Hye Young Kim (135983)

    Published 2014
    “…<p>(A) Time (3–24 hr)-dependent decrease in SIRT1 protein expression after exposure to HMGB1 (100 ng/ml), and (B) recovery of reduced SIRT1 expression by cilostazol (1–30 µM) and by resveratrol (RES, 20 µM). …”
  12. 17332
  13. 17333
  14. 17334

    SKF96365 and 2-APB inhibit Src activation. by Mengchen Zou (725646)

    Published 2015
    “…<p>Representative immunoblots showing that SKF96365 (A) and 2-APB (B) decreased HMGB1-induced Src phosphorylation. …”
  15. 17335
  16. 17336

    S4 File - by Patricia Volkow (772718)

    Published 2023
    “…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
  17. 17337

    Screening diagram. by Patricia Volkow (772718)

    Published 2023
    “…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
  18. 17338

    IL6 levels by group by protocol scheduled visit. by Patricia Volkow (772718)

    Published 2023
    “…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
  19. 17339

    S1 File - by Patricia Volkow (772718)

    Published 2023
    “…Non-severe-IRIS-KS was defined as: an increase in the number of lesions plus a decrease of ≥one log10 HIV-VL, or an increase of ≥50cells/mm3 or ≥2-fold in baseline CD4+cells. …”
  20. 17340

    Table_1_Medical errors, affected sites, and adverse consequences among patients in the orthopaedic department: Does age matter?.DOCX by Paicheng Liu (13849150)

    Published 2024
    “…However, adult patients (aged 18–60 years) were most susceptible to errors in the extremities (30.42%). A higher rate of complications was associated with a higher rate of morbidity/mortality for the corresponding patients. …”